MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis
Breast Cancer: Targets and Therapy · 2026-08 · Volume 18 · 1-15
DOI: 10.2147/bctt.s624272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-08. Verfasst von Fatih Atalah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Medical Oncology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanb…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Medical Oncology, Istanbul Medeniyet University, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul, Türkiye.
- Department of Medical Oncology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Türkiye.
- Department of Medical Oncology, Bezmialem Vakıf University Hospital, Istanbul, Türkiye.
ORCID-Profile: Fatih Atalah, Onur Alkan, Okan Aydın, Mahmut Gümüş
Zitieren
APA
Atalah, F., Acarbay, A., Karakök, A., Nazlı, İ., Alkan, O., Aydın, O., Selvi, O., Beşiroğlu, M., & Gümüş, M. (2026). MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis. Breast Cancer: Targets and Therapy, Volume 18, 1-15. https://doi.org/10.2147/bctt.s624272
Vancouver
Atalah F, Acarbay A, Karakök A, Nazlı İ, Alkan O, Aydın O, et al. MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-15. doi:10.2147/bctt.s624272
BibTeX
@article{Atalah2026,
author = {Atalah, Fatih and Acarbay, Aydın and Karakök, Akgün and Nazlı, İsmail and Alkan, Onur and Aydın, Okan and Selvi, Oğuzhan and Beşiroğlu, Mehmet and Gümüş, Mahmut},
title = {MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--15},
doi = {10.2147/bctt.s624272}
}
EUVIMED